Addressing inequality of health care

IF 8.5 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Medical Journal of Australia Pub Date : 2025-02-16 DOI:10.5694/mja2.52601
Michael Skilton
{"title":"Addressing inequality of health care","authors":"Michael Skilton","doi":"10.5694/mja2.52601","DOIUrl":null,"url":null,"abstract":"<p>Inequality in access to health services and the rising cost of the health system are both challenges to the Australian health system (https://www.health.gov.au/about-us/the-australian-health-system). A number of articles in this issue of the <i>MJA</i> are relevant to describing the nature of these challenges and how they may be addressed.</p><p>The National Disability Insurance Scheme (NDIS) replaced a disability care system that was inequitable and provided limited choice and access to appropriate support. The self-directed nature of the NDIS is designed to, at least in part, overcome these limitations and address deeply rooted barriers that hinder people with disability from fully engaging in society. In this issue, Disney and colleagues used NDIS data to quantify the inequalities in the allocation and use of NDIS support (https://doi.org/10.5694/mja2.52594). They found that older applicants, those who are women or girls, and those living in socio-economically disadvantaged areas are less likely to be deemed eligible for the NDIS. As Smith-Merry and Chang note in their associated editorial (https://doi.org/10.5694/mja2.52587), inequality of access is linked to social inequities, in addition to providing guidance for future research to inform a more tailored and inclusive approach to support provision.</p><p>Obesity is a major contributor to the burden of disease in Australia and is strongly linked with social inequalities and disadvantage. After the failure of so many previous anti-obesity medications (https://journals.biologists.com/dmm/article/5/5/621/3257/Anti-obesity-drugs-past-present-and-future), the glucagon-like peptide-1 (GLP-1) receptor agonists provide perhaps a glimpse of light at the end of the tunnel. Supported by strong evidence of both weight loss and broader health benefits, and amidst a wave of viral celebrity engagement, their worldwide usage has skyrocketed. Within this context, Kanellis and colleagues discuss the role of GLP-1 receptor agonists in obesity (https://doi.org/10.5694/mja2.52582), with a specific focus on identifying funding models and models of care relevant for Australia. By addressing these challenges, the potential of GLP-1 receptor agonists to revolutionise obesity care in a sustainable and equitable manner can be fully realised.</p><p>There are also challenges on the individual level for patients. The decline in bulk-billing by general practitioners and the current cost of living crisis have affected affordability of health care for many people. Through analysis of Medicare bulk-billing rates and out-of-pocket costs for non-bulk-billed general practitioner services, Saxby and Zhang highlight the differences in access to affordable health care on the basis of geographic region, with those in remote and socio-economically disadvantaged areas of Australia having the highest out-of-pocket costs (https://doi.org/10.5694/mja2.52562). In their associated editorial, Rosenberg and Hickie describe three issues that require redress to improve the system to a level of fairness expected by the average Australian (https://doi.org/10.5694/mja2.52580).</p><p>And finally, a medical history article that has less to do with modern challenges to the health care system, but rather provides a glimpse of health care challenges under extreme circumstances. Ariotti and Roberts-Pederson present a fascinating look at the diaries written from inside the Changi prison camp complex by prisoner-of-war Australian medical officer Major Kennedy Burnside (https://doi.org/10.5694/mja2.52581). For the thousands of his fellow prisoners-of-war in Changi, his work there played an important role in minimising the impact of their living conditions on their health. Key aspects of his work highlighted include the diagnosis, treatment and prevention of malaria and the development of a dysentery vaccine. The photos that accompany the article, taken by Burnside, provide an insight into the nature of the pathology laboratory that he established and an intriguing glimpse of life within the complex. I would recommend readers to take the time to view the full collection available on the Australian War Memorial website.</p><p>In one thought-provoking section, the authors detail how Major Burnside pondered whether his endeavours while a prisoner-of-war would have any relevance to his post-war career; he went on to have an illustrious career in medicine. Irrespective of his post-war career achievements, the value of what he did in that period, under those circumstances, cannot be overstated. In the words of Ralph Waldo Emerson, “The reward of a thing well done, is to have done it”.</p>","PeriodicalId":18214,"journal":{"name":"Medical Journal of Australia","volume":"222 3","pages":"109"},"PeriodicalIF":8.5000,"publicationDate":"2025-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.5694/mja2.52601","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Journal of Australia","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.5694/mja2.52601","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Inequality in access to health services and the rising cost of the health system are both challenges to the Australian health system (https://www.health.gov.au/about-us/the-australian-health-system). A number of articles in this issue of the MJA are relevant to describing the nature of these challenges and how they may be addressed.

The National Disability Insurance Scheme (NDIS) replaced a disability care system that was inequitable and provided limited choice and access to appropriate support. The self-directed nature of the NDIS is designed to, at least in part, overcome these limitations and address deeply rooted barriers that hinder people with disability from fully engaging in society. In this issue, Disney and colleagues used NDIS data to quantify the inequalities in the allocation and use of NDIS support (https://doi.org/10.5694/mja2.52594). They found that older applicants, those who are women or girls, and those living in socio-economically disadvantaged areas are less likely to be deemed eligible for the NDIS. As Smith-Merry and Chang note in their associated editorial (https://doi.org/10.5694/mja2.52587), inequality of access is linked to social inequities, in addition to providing guidance for future research to inform a more tailored and inclusive approach to support provision.

Obesity is a major contributor to the burden of disease in Australia and is strongly linked with social inequalities and disadvantage. After the failure of so many previous anti-obesity medications (https://journals.biologists.com/dmm/article/5/5/621/3257/Anti-obesity-drugs-past-present-and-future), the glucagon-like peptide-1 (GLP-1) receptor agonists provide perhaps a glimpse of light at the end of the tunnel. Supported by strong evidence of both weight loss and broader health benefits, and amidst a wave of viral celebrity engagement, their worldwide usage has skyrocketed. Within this context, Kanellis and colleagues discuss the role of GLP-1 receptor agonists in obesity (https://doi.org/10.5694/mja2.52582), with a specific focus on identifying funding models and models of care relevant for Australia. By addressing these challenges, the potential of GLP-1 receptor agonists to revolutionise obesity care in a sustainable and equitable manner can be fully realised.

There are also challenges on the individual level for patients. The decline in bulk-billing by general practitioners and the current cost of living crisis have affected affordability of health care for many people. Through analysis of Medicare bulk-billing rates and out-of-pocket costs for non-bulk-billed general practitioner services, Saxby and Zhang highlight the differences in access to affordable health care on the basis of geographic region, with those in remote and socio-economically disadvantaged areas of Australia having the highest out-of-pocket costs (https://doi.org/10.5694/mja2.52562). In their associated editorial, Rosenberg and Hickie describe three issues that require redress to improve the system to a level of fairness expected by the average Australian (https://doi.org/10.5694/mja2.52580).

And finally, a medical history article that has less to do with modern challenges to the health care system, but rather provides a glimpse of health care challenges under extreme circumstances. Ariotti and Roberts-Pederson present a fascinating look at the diaries written from inside the Changi prison camp complex by prisoner-of-war Australian medical officer Major Kennedy Burnside (https://doi.org/10.5694/mja2.52581). For the thousands of his fellow prisoners-of-war in Changi, his work there played an important role in minimising the impact of their living conditions on their health. Key aspects of his work highlighted include the diagnosis, treatment and prevention of malaria and the development of a dysentery vaccine. The photos that accompany the article, taken by Burnside, provide an insight into the nature of the pathology laboratory that he established and an intriguing glimpse of life within the complex. I would recommend readers to take the time to view the full collection available on the Australian War Memorial website.

In one thought-provoking section, the authors detail how Major Burnside pondered whether his endeavours while a prisoner-of-war would have any relevance to his post-war career; he went on to have an illustrious career in medicine. Irrespective of his post-war career achievements, the value of what he did in that period, under those circumstances, cannot be overstated. In the words of Ralph Waldo Emerson, “The reward of a thing well done, is to have done it”.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
解决保健不平等问题
获得卫生服务的不平等和卫生系统成本的上升都是澳大利亚卫生系统面临的挑战(https://www.health.gov.au/about-us/the-australian-health-system)。本期MJA中的许多文章都与描述这些挑战的性质以及如何解决这些挑战有关。国家残疾保险计划(NDIS)取代了不公平的残疾护理系统,该系统提供的选择和获得适当支助的机会有限。NDIS的自我导向性质旨在(至少在一定程度上)克服这些限制,解决阻碍残疾人充分参与社会的根深蒂固的障碍。在本期中,Disney及其同事使用NDIS数据量化了NDIS支持分配和使用中的不平等(https://doi.org/10.5694/mja2.52594)。他们发现,年龄较大的申请人、妇女或女孩以及生活在社会经济不利地区的申请人不太可能被认为有资格获得NDIS。正如Smith-Merry和Chang在他们的联合社论(https://doi.org/10.5694/mja2.52587)中指出的那样,获取机会的不平等与社会不平等有关,此外还为未来的研究提供指导,以便为更有针对性和包容性的支持提供方法提供信息。肥胖是造成澳大利亚疾病负担的一个主要因素,与社会不平等和不利处境密切相关。在许多先前的抗肥胖药物失败之后(https://journals.biologists.com/dmm/article/5/5/621/3257/Anti-obesity-drugs-past-present-and-future),胰高血糖素样肽-1 (GLP-1)受体激动剂可能提供了隧道尽头的曙光。有强有力的证据表明,它既能减肥,又能带来更广泛的健康益处,再加上一波名人参与的热潮,它们在全球的使用率直线上升。在此背景下,Kanellis及其同事讨论了GLP-1受体激动剂在肥胖中的作用(https://doi.org/10.5694/mja2.52582),并特别关注于确定与澳大利亚相关的资助模式和护理模式。通过解决这些挑战,GLP-1受体激动剂以可持续和公平的方式彻底改变肥胖治疗的潜力可以充分实现。在患者个人层面上也存在挑战。全科医生批量计费的减少和当前的生活成本危机影响了许多人的医疗负担能力。Saxby和Zhang通过对医疗保险批量计费率和非批量计费全科医生服务的自付费用的分析,强调了地理区域在获得可负担医疗保健方面的差异,澳大利亚偏远地区和社会经济不利地区的自付费用最高(https://doi.org/10.5694/mja2.52562)。在他们的联合社论中,Rosenberg和Hickie描述了三个需要纠正的问题,以改善系统,使其达到平均澳大利亚人所期望的公平水平(https://doi.org/10.5694/mja2.52580).And最后,一篇与医疗保健系统的现代挑战无关的医学历史文章,而是提供了极端情况下医疗保健挑战的一瞥。阿里奥蒂和罗伯茨-佩德森对澳大利亚战俘军医肯尼迪·伯恩赛德少校(Major Kennedy Burnside)在樟宜战俘营写的日记进行了精彩的介绍(https://doi.org/10.5694/mja2.52581)。对于他在樟宜的数千名战俘同伴来说,他在那里的工作在尽量减少他们的生活条件对他们健康的影响方面发挥了重要作用。他的工作重点包括疟疾的诊断、治疗和预防以及痢疾疫苗的研制。文章附带的照片由伯恩赛德拍摄,提供了对他建立的病理实验室性质的洞察,以及对复杂生物的有趣一瞥。我建议读者花点时间在澳大利亚战争纪念馆网站上浏览完整的收藏。在一个发人深省的章节中,作者详细描述了伯恩赛德少校如何思考他在战俘时期所做的努力是否与他战后的职业生涯有关;他后来在医学上取得了辉煌的成就。不管他战后的职业成就如何,在那种情况下,他在那个时期所做的事情的价值怎么强调都不为过。用拉尔夫·沃尔多·爱默生的话来说,“做好一件事的回报,就是去做这件事”。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Medical Journal of Australia
Medical Journal of Australia 医学-医学:内科
CiteScore
9.40
自引率
5.30%
发文量
410
审稿时长
3-8 weeks
期刊介绍: The Medical Journal of Australia (MJA) stands as Australia's foremost general medical journal, leading the dissemination of high-quality research and commentary to shape health policy and influence medical practices within the country. Under the leadership of Professor Virginia Barbour, the expert editorial team at MJA is dedicated to providing authors with a constructive and collaborative peer-review and publication process. Established in 1914, the MJA has evolved into a modern journal that upholds its founding values, maintaining a commitment to supporting the medical profession by delivering high-quality and pertinent information essential to medical practice.
期刊最新文献
Hearing Justice Through a Stethoscope: Advocacy, Climate Change and Medicine's Upstream Responsibilities National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025 Integrating Coronary Artery Calcium Scoring Into Cardiovascular Prevention in Australia The Association Between Access Block And Ambulance Ramping, And The Impact of COVID-19: A Retrospective Observational Cohort Study of 25 Queensland Hospitals Issue Information
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1